Home >   Products   >  Advanced Search

Gatifloxacin Hydrate
(CAS RN:614751-80-3 Product Number:G0325)

Structure

Gatifloxacin
Synonym 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid Hydrate

General Information

Product Number G0325

* Items available from stock in Japan will be delivered in 1-2 weeks.
* Please contact us if you need further information.
(Sales Dept Tel: 800-423-8616 / 503-283-1681 E-mail: Sales-US@TCIchemicals.com)
* To send your quote request for bulk quantities, please click on the “Request Bulk Quotation” button. Please note that we cannot offer bulk quantities for some products.
* TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.

Purity/Analysis Method >98.0%(HPLC)
Storage Temperature 0-10°C
M.F. / M.W. C19H22FN3O4·xH2O=375.40(as Anhydrous)
CAS RN 614751-80-3
Related CAS RN 112811-59-3,180200-66-2
MDL Number
  • Product Details
  • Safety & Regulations
  • Reference & Application

Specification

Purity(HPLC) min. 98.0 area%
Purity(Neutralization titration) min. 95.0 %(calcd.on anh.substance)
Melting point 180.0 to 184.0 deg-C
Water 4.5 to 9.0 %

References

PubChem SID 354335684

Transport Information

HS Number 2933.59.3600

Application

Gatifloxacin: An 8-Methoxy Fluoroquinolone Antibacterial Agent with a Broad Antibacterial Spectrum

Gatifloxacin (AM-1155) is an 8-methoxy fluoroquinolone antibacterial agent with a 3-methylpiperazinyl substituent at C7. Fluoroquinolone fungicidal antibacterial agents are inhibitor of bacterial DNA gyrase and topoisomerase IV. 1,2) DNA gyrase is an essential enzyme that is involved in the replication, transcription, and repair of bacterial DNA. Topoisomerase IV is an enzyme known to play a key role in the partitioning of the chromosomal DNA during bacterial cell division. As just described, the mechanism of action of fluoroquinolones is different from the other antibiotics. Therefore, there is no cross-resistance between fluoroquinolones and the other classes of antibiotics. In particular, gatifloxacin has a broader spectrum of antibacterial activity than the older fluoroquinolones and shows good activity against many Gram-positive and Gram-negive bacteria, atypical organisms and some anaerobes. 3) Furthermore, gatifloxacin possesses a higher selectivity for bacterial type II topoisomerases.4) (The product is for research purpose only.)

References

Page Top